Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction

Creative Commons License

Allen J. K., Armaiz-Pena G. N., Nagaraja A. S., Sadaoui N. C., Ortiz T., Dood R., ...Daha Fazla

CANCER RESEARCH, cilt.78, sa.12, ss.3233-3242, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 12
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1158/0008-5472.can-16-1701
  • Dergi Adı: CANCER RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3233-3242
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Mounting clinical and preclinical evidence supports a key role for sustained adrenergic signaling in the tumor microenvironment as a driver of tumor growth and progression. However, the mechanisms by which adrenergic neurotransmitters are delivered to the tumor microenvironment are not well understood. Here we present evidence for a feed-forward loop whereby adrenergic signaling leads to increased tumoral innervation. In response to catecholamines, tumor cells produced brain-derived neurotrophic factor (BDNF) in an ADRB3/cAMP/ Epac/JNK-dependent manner. Elevated BDNF levels in the tumor microenvironment increased innervation by signaling through host neurotrophic receptor tyrosine kinase 2 receptors. In patients with cancer, high tumor nerve counts were significantly associated with increased BDNF and norepinephrine levels and decreased overall survival. Collectively, these data describe a novel pathway for tumor innervation, with resultant biological and clinical implications.